Lumos Diagnostics Holdings (ASX:LDX) EV-to-EBIT : -3.09 (As of May. 10, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Lumos Diagnostics Holdings's Enterprise Value is A$23.75 Mil. Lumos Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was A$-7.68 Mil. Therefore, Lumos Diagnostics Holdings's EV-to-EBIT for today is -3.09.

The historical rank and industry rank for Lumos Diagnostics Holdings's EV-to-EBIT or its related term are showing as below:

ASX:LDX' s EV-to-EBIT Range Over the Past 10 Years
Min: -3.19 Med: -1.49 Max: -0.01
Current: -3.09

During the past 3 years, the highest EV-to-EBIT of Lumos Diagnostics Holdings was -0.01. The lowest was -3.19. And the median was -1.49.

ASX:LDX's EV-to-EBIT is ranked worse than
100% of 453 companies
in the Medical Devices & Instruments industry
Industry Median: 18.93 vs ASX:LDX: -3.09

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Lumos Diagnostics Holdings's Enterprise Value for the quarter that ended in Dec. 2024 was A$29.79 Mil. Lumos Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was A$-7.68 Mil. Lumos Diagnostics Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -25.78%.

Lumos Diagnostics Holdings EV-to-EBIT Historical Data

The historical data trend for Lumos Diagnostics Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings EV-to-EBIT Chart

Lumos Diagnostics Holdings Annual Data

Trend

Jun22

Jun23

Jun24

EV-to-EBIT

-0.44

-1.05

-1.42

Lumos Diagnostics Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-EBIT	Get a 7-Day Free Trial			-	-1.05	-	-1.42	-

Competitive Comparison of Lumos Diagnostics Holdings's EV-to-EBIT

For the Medical Devices subindustry, Lumos Diagnostics Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumos Diagnostics Holdings's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lumos Diagnostics Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Lumos Diagnostics Holdings EV-to-EBIT Calculation

Lumos Diagnostics Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	23.748	/	-7.68
	=	-3.09

Lumos Diagnostics Holdings's current Enterprise Value is A$23.75 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lumos Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was A$-7.68 Mil.

Lumos Diagnostics Holdings (ASX:LDX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Lumos Diagnostics Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 )	=	EBIT	/	Enterprise Value (Q: Dec. 2024 )
	=	-7.68	/	29.790305
	=	-25.78 %

Lumos Diagnostics Holdings's Enterprise Value for the quarter that ended in Dec. 2024 was A$29.79 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lumos Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was A$-7.68 Mil.

Lumos Diagnostics Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumos Diagnostics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

LDXHF:USA

Address

2724 Loker Avenue West, Carlsbad, CA, USA, 92010

Website

https://www.lumosdiagnostics.com

Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture, and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. The group is dedicated to providing contract research and development services, focusing on the innovation, development, manufacturing, and commercialization of point-of-care diagnostic solutions for both clinical and consumer applications. It generates maximum revenue from commercial services and solutions relating to POC diagnostic tests. The group has one operating segment, which is the provision of point-of-care diagnostics goods and services, and it operates across two geographical regions, the United States and Australia. and the majority of revenue is generated from the United States.

Lumos Diagnostics Holdings Headlines

No Headlines